{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:01:12Z","timestamp":1790697672832,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["DRUMM22G0-COLLAB"],"award-info":[{"award-number":["DRUMM22G0-COLLAB"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["2022FRSS2H"],"award-info":[{"award-number":["2022FRSS2H"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","award":["Assael08A0"],"award-info":[{"award-number":["Assael08A0"]}],"id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000292","name":"Cystic Fibrosis Trust","doi-asserted-by":"publisher","award":["SRC020 \/ ALLEN20XX"],"award-info":[{"award-number":["SRC020 \/ ALLEN20XX"]}],"id":[{"id":"10.13039\/501100000292","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.isci.2025.111979","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:30:27Z","timestamp":1740108627000},"page":"111979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Adenine base editing with engineered virus-like particles rescues the CFTR mutation G542X in patient-derived intestinal organoids"],"prefix":"10.1016","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-7767-7808","authenticated-orcid":false,"given":"Lucia","family":"Nicosia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iwona","family":"Pranke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta V.","family":"Latorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joss B.","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Lonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kader","family":"Cavusoglu-Doran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Dreano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Costello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Melotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Sorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Sermet-Gaudelus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina F.","family":"Scallan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick T.","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2025.111979_bib1","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jcf.2022.01.009","article-title":"Worldwide rates of diagnosis and effective treatment for cystic fibrosis","volume":"21","author":"Guo","year":"2022","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.isci.2025.111979_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrg3849","article-title":"Cystic fibrosis genetics: From molecular understanding to clinical application","volume":"16","author":"Cutting","year":"2015","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.isci.2025.111979_bib3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s40272-013-0035-3","article-title":"Managing the underlying cause of cystic fibrosis: A future role for potentiators and correctors","volume":"15","author":"Galietta","year":"2013","journal-title":"Paediatr. Drugs"},{"key":"10.1016\/j.isci.2025.111979_bib4","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.111979_bib5","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1056\/NEJMoa1709846","article-title":"Tezacaftor\u2013Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del","volume":"377","author":"Taylor-Cousar","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.111979_bib6","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMoa1807120","article-title":"VX-445\u2013Tezacaftor\u2013Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles","volume":"379","author":"Keating","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.111979_bib7","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","article-title":"Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial","volume":"394","author":"Heijerman","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2025.111979_bib8","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","article-title":"Elexacaftor\u2013Tezacaftor\u2013Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele","volume":"381","author":"Middleton","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.isci.2025.111979_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112436","article-title":"Pharmacological approaches for targeting cystic fibrosis nonsense mutations","volume":"200","author":"Sharma","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.isci.2025.111979_bib10","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1165\/rcmb.2019-0291OC","article-title":"Novel correctors and potentiators enhance translational readthrough in CFTR nonsense mutations","volume":"64","author":"Mutyam","year":"2021","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.isci.2025.111979_bib11","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.jcf.2019.02.009","article-title":"Decreased mRNA and protein stability of W1282X limits response to modulator therapy","volume":"18","author":"Aksit","year":"2019","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.isci.2025.111979_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-29935-9","article-title":"CFTR mRNAs with nonsense codons are degraded by the SMG6-mediated endonucleolytic decay pathway","volume":"13","author":"Sanderlin","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.111979_bib13","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.stem.2013.11.002","article-title":"Functional repair of CFTR by CRISPR\/Cas9 in intestinal stem cell organoids of cystic fibrosis patients","volume":"13","author":"Schwank","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.isci.2025.111979_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11454-9","article-title":"Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing","volume":"10","author":"Maule","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.111979_bib15","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.stem.2020.01.019","article-title":"CRISPR-Based Adenine Editors Correct Nonsense Mutations in a Cystic Fibrosis Organoid Biobank","volume":"26","author":"Geurts","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.isci.2025.111979_bib16","article-title":"Prime editing-mediated correction of the CFTR W1282X mutation in iPSCs and derived airway epithelial cells","volume":"18","author":"Li","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/j.isci.2025.111979_bib17","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1038\/s41587-020-0561-9","article-title":"Genome editing with CRISPR\u2013Cas nucleases, base editors, transposases and prime","volume":"38","author":"Anzalone","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2025.111979_bib18","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.molcel.2021.12.026","article-title":"CRISPR-based genome editing through the lens of DNA repair","volume":"82","author":"Nambiar","year":"2022","journal-title":"Mol. Cell"},{"key":"10.1016\/j.isci.2025.111979_bib19","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/nature24644","article-title":"Programmable base editing of T to G C in genomic DNA without DNA cleavage","volume":"551","author":"Gaudelli","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.111979_bib20","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1038\/s41587-020-0453-z","article-title":"Phage-assisted evolution of an adenine base editor with improved Cas domain compatibility and activity","volume":"38","author":"Richter","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2025.111979_bib21","doi-asserted-by":"crossref","first-page":"3237","DOI":"10.1093\/hmg\/ddad143","article-title":"Use of adenine base editing and homology-independent targeted integration strategies to correct the cystic fibrosis causing variant, W1282X","volume":"32","author":"Mention","year":"2023","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.isci.2025.111979_bib22","doi-asserted-by":"crossref","first-page":"10558","DOI":"10.1093\/nar\/gkab788","article-title":"Functional correction of CFTR mutations in human airway epithelial cells using adenine base editors","volume":"49","author":"Krishnamurthy","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2025.111979_bib23","doi-asserted-by":"crossref","first-page":"12508","DOI":"10.1073\/pnas.1605336113","article-title":"Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression","volume":"113","author":"Roy","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.isci.2025.111979_bib24","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1093\/hmg\/ddx196","article-title":"Identification of the amino acids inserted during suppression of CFTR nonsense mutations and determination of their functional consequences","volume":"26","author":"Xue","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.isci.2025.111979_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fmolb.2022.921680","article-title":"Pharmacological Responses of the G542X-CFTR to CFTR Modulators","volume":"9","author":"Fang","year":"2022","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.isci.2025.111979_bib26","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00080-2017","article-title":"Factors influencing readthrough therapy for frequent cystic fibrosis premature termination codons","volume":"4","author":"Pranke","year":"2018","journal-title":"ERJ Open Res."},{"key":"10.1016\/j.isci.2025.111979_bib27","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.02379-2018","article-title":"Intestinal organoids to model cystic fibrosis","volume":"54","author":"Van Mourik","year":"2019","journal-title":"Eur. Respir. J."},{"key":"10.1016\/j.isci.2025.111979_bib28","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-28137-7","article-title":"Improved gRNA secondary structures allow editing of target sites resistant to CRISPR-Cas9 cleavage","volume":"13","author":"Riesenberg","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.111979_bib29","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1016\/j.cell.2013.12.001","article-title":"Dynamic imaging of genomic loci in living human cells by an optimized CRISPR\/Cas system","volume":"155","author":"Chen","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.111979_bib30","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.cell.2021.12.021","article-title":"Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins","volume":"185","author":"Banskota","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.isci.2025.111979_bib31","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1038\/s41587-019-0032-3","article-title":"CRISPResso2 provides accurate and rapid genome editing sequence analysis","volume":"37","author":"Clement","year":"2019","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2025.111979_bib32","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41576-018-0059-1","article-title":"Base editing: precision chemistry on the genome and transcriptome of living cells","volume":"19","author":"Rees","year":"2018","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.isci.2025.111979_bib33","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1038\/nbt.2647","article-title":"DNA targeting specificity of RNA-guided Cas9 nucleases","volume":"31","author":"Hsu","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2025.111979_bib34","doi-asserted-by":"crossref","first-page":"W242","DOI":"10.1093\/nar\/gky354","article-title":"CRISPOR: Intuitive guide selection for CRISPR\/Cas9 genome editing experiments and screens","volume":"46","author":"Concordet","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.isci.2025.111979_bib35","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.ymthe.2020.11.009","article-title":"Single-Base Resolution: Increasing the Specificity of the CRISPR-Cas System in Gene Editing","volume":"29","author":"Rabinowitz","year":"2021","journal-title":"Mol. Ther."},{"key":"10.1016\/j.isci.2025.111979_bib36","doi-asserted-by":"crossref","DOI":"10.26508\/lsa.202201857","article-title":"Validating organoid-derived human intestinal monolayers for personalized therapy in cystic fibrosis","volume":"6","author":"Birimberg-Schwartz","year":"2023","journal-title":"Life Sci. Alliance"},{"key":"10.1016\/j.isci.2025.111979_bib37","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.3390\/ijms23031437","article-title":"Assays of CFTR Function In Vitro, Ex Vivo and In Vivo","volume":"23","author":"Ramalho","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2025.111979_bib38","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jcf.2004.05.026","article-title":"Transepithelial electrical measurements with the Ussing chamber","volume":"3","author":"Li","year":"2004","journal-title":"J. Cyst. Fibros."},{"key":"10.1016\/j.isci.2025.111979_bib39","article-title":"Forskolin-induced swelling in intestinal organoids: An in vitro assay for assessing drug response in cystic fibrosis patients","volume":"2017","author":"Boj","year":"2017","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.isci.2025.111979_bib40","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/nm.3201","article-title":"A functional CFTR assay using primary cystic fibrosis intestinal organoids","volume":"19","author":"Dekkers","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2025.111979_bib41","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1074\/jbc.M116.764720","article-title":"Correctors and potentiators rescue function of the truncated W1282X-Cystic Fibrosis Transmembrane Regulator (CFTR) translation product","volume":"292","author":"Haggie","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.isci.2025.111979_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2023.101177","article-title":"Genetic surgery for a cystic fibrosis-causing splicing mutation","volume":"32","author":"Bulcaen","year":"2024","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.isci.2025.111979_bib43","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-42948-2","article-title":"Lung SORT LNPs enable precise homology-directed repair mediated CRISPR\/Cas genome correction in cystic fibrosis models","volume":"14","author":"Wei","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.isci.2025.111979_bib44","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/s41586-021-03609-w","article-title":"Base editing of haematopoietic stem cells rescues sickle cell disease in mice","volume":"595","author":"Newby","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.111979_bib45","first-page":"1","article-title":"Directed evolution of engineered virus-like particles with improved production and transduction efficiencies","author":"Raguram","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2025.111979_bib46","article-title":"Prime editing functionally corrects cystic fibrosis-causing CFTR mutations in human organoids and airway epithelial cells","volume":"5","author":"Bulcaen","year":"2024","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.isci.2025.111979_bib47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/ng0992-21","article-title":"Efficiency of gene transfer for restoration of normal airway epithelial function in cystic fibrosis","volume":"2","author":"Johnson","year":"1992","journal-title":"Nat. Genet."},{"key":"10.1016\/j.isci.2025.111979_bib48","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/s41587-023-01821-9","article-title":"Adenine transversion editors enable precise, efficient A\u2022T-to-C\u2022G base editing in mammalian cells and embryos","volume":"42","author":"Chen","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2025.111979_bib49","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1038\/s41587-022-01595-6","article-title":"Programmable A-to-Y base editing by fusing an adenine base editor with an N-methylpurine DNA glycosylase","volume":"41","author":"Tong","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2025.111979_bib50","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/s41587-023-02085-z","article-title":"In vivo human T cell engineering with enveloped delivery vehicles","volume":"42","author":"Hamilton","year":"2024","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2025.111979_bib51","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.isci.2025.111979_bib52","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/s41587-023-01678-y","article-title":"Prediction of prime editing insertion efficiencies using sequence features and DNA repair determinants","volume":"41","author":"Koeppel","year":"2023","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.isci.2025.111979_bib53","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/cge.12802","article-title":"mRNA-based detection of rare CFTR mutations improves genetic diagnosis of cystic fibrosis in populations with high genetic heterogeneity","volume":"91","author":"Fel\u00edcio","year":"2017","journal-title":"Clin. Genet."},{"key":"10.1016\/j.isci.2025.111979_bib54","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nmeth.2019","article-title":"Fiji: An open-source platform for biological-image analysis","volume":"9","author":"Schindelin","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.isci.2025.111979_bib55","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24065199","article-title":"CFTR Modulators Rescue the Activity of CFTR in Colonoids Expressing the Complex Allele p.[R74W;V201M;D1270N]\/dele22_24","volume":"24","author":"Kleinfelder","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2025.111979_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210358","article-title":"Theratyping of the Rare CFTR Genotype A559T in Rectal Organoids and Nasal Cells Reveals a Relevant Response to Elexacaftor (VX-445) and Tezacaftor (VX-661) Combination","volume":"24","author":"Kleinfelder","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.isci.2025.111979_bib57","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00110-2023","article-title":"Theratyping cystic fibrosis patients to guide elexacaftor\/tezacaftor\/ivacaftor out-of-label prescription","volume":"62","author":"Dreano","year":"2023","journal-title":"Eur. Respir. J."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225002391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004225002391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T01:17:19Z","timestamp":1786411039000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004225002391"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":57,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2589004225002391"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2025.111979","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adenine base editing with engineered virus-like particles rescues the CFTR mutation G542X in patient-derived intestinal organoids","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2025.111979","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"111979"}}